login
login

Europe Daily Bulletin No. 7862

13 December 2000
Contents Publication in full By article 26 / 51
ECONOMIC INTERPENETRATION / (eu) pharmaceuticals

Britain's SHIRE PHARMACEUTICALS is to take over the Canadian firm BIOHEM PHARMA through a transaction valuing the firm at $4 bn. The merger of the two companies will give rise to the creation of "one of the world's foremost pharmaceutical groups" with an annual turnover of $587 million (based on 1999) and a stock market capitalisation of $8.5 bn. The operation will take the form of a share swap, each BIOCHEM share valued at $37.

Contents

A LOOK BEHIND THE NEWS
THE DAY IN POLITICS
GENERAL NEWS
ECONOMIC INTERPENETRATION